M21-841 NOA Volume - Mid Face US Pivotal Study
Research payments
$104,130
Through program year 2025, $104,130 in research payments was reported against M21-841 NOA Volume - Mid Face US Pivotal Study, across 15 payments, paid by AbbVie, Inc..
- Paid by
- AbbVie, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $5,743 | 3 |
| 2024 | Research | $32,731 | 3 |
| 2023 | Research | $65,656 | 9 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
8 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Ira Papel Baltimore, MD Named on 2 payments
- Katherine Holcomb Metairie, LA Named on 2 payments
- Melanie Appell Birmingham, AL Named on 1 payment
- Jeremy Green Coral Gables, FL Named on 1 payment
- Alia Brown Snellville, GA Named on 1 payment
- William Werschler Spokane, WA Named on 1 payment
- Oscar Hevia Coral Gables, FL Named on 1 payment
- Keimun Slaughter Latham, NY Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.